Fox Jonathan C - Jun 10, 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Stock symbol
EWTX
Transactions as of
Jun 10, 2024
Transactions value $
$0
Form type
4
Date filed
6/12/2024, 07:32 PM
Previous filing
Dec 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +20.6K $0.00 20.6K Jun 10, 2024 Common Stock 20.6K $17.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders.